Cargando…
Glucose restriction combined with chemotherapy decreases telomere length and cancer antigen-125 secretion in ovarian carcinoma
Although chemotherapy is the standard treatment for ovarian cancer (OC), recent studies have focused on its coupling with hypoglycemic drugs to decrease glucose availability. Similarly to cancer antigen 125 (Ca-125), telomerase, the key protein for telomere lengthening, is overexpressed in 90% of OC...
Autores principales: | Antoun, Stephanie, Atallah, David, Tahtouh, Roula, Assaf, Mona Diab, Moubarak, Malak, Ayoub, Eliane Nasser, Chahine, Georges, Hilal, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956372/ https://www.ncbi.nlm.nih.gov/pubmed/31966066 http://dx.doi.org/10.3892/ol.2019.11233 |
Ejemplares similares
-
Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles
por: Antoun, Stephanie, et al.
Publicado: (2018) -
HSP27 modulates tumoural immune evasion by enhancing STAT3-mediated upregulation of PD-L1 and NLRC5 in ovarian cancer
por: Fezza, Maha, et al.
Publicado: (2023) -
Telomerase Inhibition Decreases Alpha-Fetoprotein Expression and Secretion by Hepatocellular Carcinoma Cell Lines: In Vitro and In Vivo Study
por: Tahtouh, Roula, et al.
Publicado: (2015) -
Radiology management of a ‘breast unit’ during COVID-19 pandemic: a single institution experience
por: Salem, Christine, et al.
Publicado: (2020) -
Breast Density and Breast Cancer Incidence in the Lebanese Population: Results from a Retrospective Multicenter Study
por: Salem, Christine, et al.
Publicado: (2017)